TFS and Siemens hope to have process analysis down PAT

By Gareth Macdonald

- Last updated on GMT

Related tags: Thermo fisher scientific, Thermo electron, Pharmacology

TFS and Siemens hope to have process analysis down PAT
US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production.

The new solution combines Thermo Fisher Scientific’s widely used Antaris line of Fourier Transform Near infrared analysers (FT-NIR) with Siemens’ Sipat control software platform in an approach that, the firms claim, can provide advanced process understanding and control data.

in-PharmaTechnologist spoke with Jeffrey Hirsch from Thermo Fisher Scientific and Frederik Jaenen from Siemens about the motivation for the project and what the combined technology can offer drugmakers.

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us


View more